Polymorphisms in TNFRSF1B, IL10, IL17, and IL6 were found to be associated with long-term response to anti-TNF therapy among pediatric CD patients, while this correlation was not found in adults, which revealed that the pharmacogenetics differs between adults and children (13). This evidence concerns the gene TNF and Cowden disease.